Fulcrum Therapeutics (FULC) PT Raised to $15 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Gregory Renza raised the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $15.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
